½ÃÀ庸°í¼­
»óǰÄÚµå
1587522

´ëµ¿¸ÆÆÇ ġȯ ±â±â ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : Á¦Ç°º°, ÆÇ¸· Àç·áº°, ÇÁ·¹ÀÓ Àç·áº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2025-2030³â)

Aortic Valve Replacement Devices Market Size, Share & Trends Analysis Report By Product, By Leaflet Material (Bovine Pericardium, Porcine Pericardium), By Frame Material, By End-use, By Region, And Segment Forecasts, 2025 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 100 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

´ëµ¿¸ÆÆÇ ġȯ ±â±â ½ÃÀå ¼ºÀå ¹× µ¿Çâ:

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é, ´ëµ¿¸ÆÆÇ ±³Ã¼ ±â±â ¼¼°è ½ÃÀå ±Ô¸ð´Â 2025³âºÎÅÍ 2030³â±îÁö 10.1%ÀÇ CAGRÀ» ±â·ÏÇÏ¿© 2030³â±îÁö 127¾ï 6,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

´ëµ¿¸ÆÆÇÀÇ ±â¼úÀû Áøº¸¿Í À¯¸®ÇÑ »óȯ Á¤Ã¥ÀÌ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÃÖ¼Òħ½À ¼ö¼ú¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡µµ ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù.

³ëÀÎ Àα¸ÀÇ Àúº¯ È®´ë´Â ÁÖ¿ä ¼ºÀå ÃËÁø¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ¸ÞµðÄÉ¾î ¹× ¸ÞµðÄÉÀÌµå ¼­ºñ½º¿¡¼­ ¹ßÇ¥ÇÑ µ¥ÀÌÅÍ¿¡ µû¸£¸é, ¹Ì±¹ ³» 65¼¼ ÀÌ»ó ´ëµ¿¸ÆÆÇ¸· ÇùÂøÁõ ȯÀÚ ¼ö°¡ Áö¼ÓÀûÀ¸·Î Áõ°¡Çϰí ÀÖ½À´Ï´Ù. µû¶ó¼­ ´ëµ¿¸ÆÆÇ¸·ÇùÂøÁõ ¹ßº´·ü Áõ°¡¿Í Ä¡·áÀ² °³¼±ÀÌ °áÇÕÇÏ¿© ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ¶ÇÇÑ, ÃÖ¼Òħ½À ¼ö¼ú¿¡ ´ëÇÑ ¼±È£µµ°¡ ³ô¾ÆÁö¸é¼­ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼ö¼úÀº ±âÁ¸ÀÇ °³½É¼ú¿¡ ºñÇØ ȯÀÚÀÇ ¿Ü»óÀÌ Àû°í ȸº¹ÀÌ ºü¸£¸ç, ÀÔ¿ø ±â°£ÀÌ »ó´ëÀûÀ¸·Î ª±â ¶§¹®¿¡ ±âÁ¸ÀÇ Ä§½ÀÀû ¼ö¼úº¸´Ù °æÁ¦ÀûÀ¸·Îµµ ´õ ³ªÀº °á°ú¸¦ ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

¿ìÈ£ÀûÀÎ »óȯ Á¤Ã¥Àº °¡±î¿î Àå·¡¿¡ ½ÃÀåÀ» ÁÖµµÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â Áß¿äÇÑ ¿äÀÎ Áß ÇϳªÀÔ´Ï´Ù. ¸ÞµðÄÉ¾î ¹× ¸ÞµðÄÉÀÌµå ¼­ºñ½º ¼¾ÅÍ(CMS)´Â Medicare National Coverage Determination policy(Medicare National Coverage Determination policy)¿¡ µû¶ó TAVR¿¡ ´ëÇÑ º¸Çè Àû¿ëÀ» Á¦°øÇÑ´Ù°í ¹ßÇ¥Çß½À´Ï´Ù. ¶ÇÇÑ, ÁÖ¿ä ¾÷üµéÀÌ ÁßÀç ¹üÀ§ È®´ë, ±â±â ¾ÈÀü¼º ºÐ¼®, ÈÄ¼Ó Ä¡·á ¿É¼Ç Æò°¡¸¦ À§ÇØ ¼öÇàÇÏ´Â ÀÓ»ó ¿¬±¸ÀÇ ¼ö°¡ Áõ°¡Çϰí ÀÖ´Â °Íµµ ÀÌ ½ÃÀå¿¡ À¯¸®ÇÏ°Ô ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ¾ÈÀü¼º ¹®Á¦·Î ÀÎÇÑ Á¦Ç° ȸ¼ö°¡ ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

´ëµ¿¸ÆÆÇ ġȯ ±â±â ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

  • dz¼± È®ÀåÇü ¹ëºê, 2024³â ¸ÅÃâ Á¡À¯À² 68.7%·Î ½ÃÀå µ¶Á¡ dz¼± È®ÀåÇü ¹ëºê´Â ¹ëºêÀÇ À̵¿ À§ÇèÀÌ Àû°í ½Å·ÚÇÒ ¼ö ÀÖ´Â Ä¡·á °á°ú¸¦ ¾òÀ» ¼ö ÀÖ¾î Á¡Á¡ ´õ ¼±È£µµ°¡ ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù.
  • ¼Ò ½É³¶ ºÎ¹®Àº ¿ì¼öÇÑ ±â°èÀû Ư¼º°ú »ýüÀûÇÕ¼ºÀ¸·Î ÀÎÇØ 2024³â ¸ÅÃâ Á¡À¯À² 72.5%·Î ½ÃÀåÀ» ÁÖµµÇß½À´Ï´Ù.
  • ÄÚ¹ßÆ® Å©·Ò ÇÁ·¹ÀÓÀº 2024³â 64.0%ÀÇ ÃÖ´ë ½ÃÀå Á¡À¯À²À» Â÷ÁöÇßÀ¸¸ç, °­µµ, ³»±¸¼º, ³»½Ä¼º µî ¶Ù¾î³­ ±â°èÀû Ư¼ºÀ» º¸¿© TAVR ±â±â Á¦ÀÛ¿¡ ÀÌ»óÀûÀÔ´Ï´Ù.
  • ÀÔ¿ø ½Ã¼³ÀÌ 2024³â 92.2%ÀÇ Á¡À¯À²À» Â÷ÁöÇÏ¸ç ½ÃÀåÀ» Àå¾ÇÇß½À´Ï´Ù. º´¿ø°ú Ŭ¸®´ÐÀº °í±Þ ÀÇ·á ÀÎÇÁ¶ó, ¼÷·ÃµÈ ÀηÂ, ´ëµ¿¸ÆÆÇ ¼ö¼ú·Î ÀÎÇÑ ÀáÀçÀû ÇÕº´ÁõÀ» °ü¸®ÇÏ´Â µ¥ ÇʼöÀûÀÎ ¼ö¼ú ÈÄ ¸ð´ÏÅ͸µÀ» °®Ãß°í ÀÖ½À´Ï´Ù.
  • ºÏ¹Ì ´ëµ¿¸ÆÆÇ ġȯ ±â±â ½ÃÀåÀº 2024³â 59.7%ÀÇ ¸ÅÃâ Á¡À¯À²·Î ¼¼°è ½ÃÀåÀ» Àå¾ÇÇß½À´Ï´Ù. ºÏ¹Ì´Â ¼±ÁøÀûÀÎ ÀÇ·á ÀÎÇÁ¶ó¸¦ ÀÚ¶ûÇϸç, ´ëµ¿¸ÆÆÇ¸· ÇùÂøÁõ À¯º´·üÀÌ ³ô°í ÀÇ·á ±â¼ú¿¡ ¸¹Àº ÅõÀÚ¸¦ Çϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ´ëµ¿¸ÆÆÇ ġȯ ±â±â ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

  • ½ÃÀå °èÅë Àü¸Á
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
  • ºñÁî´Ï½º ȯ°æ ºÐ¼®
    • ¾÷°è ºÐ¼® - Porter's Five Forces ºÐ¼®
    • PESTLE ºÐ¼®

Á¦4Àå ´ëµ¿¸ÆÆÇ ġȯ ±â±â ½ÃÀå : Á¦Ç° ºñÁî´Ï½º ºÐ¼®

  • Á¦Ç° ½ÃÀå Á¡À¯À², 2024³â ¹× 2030³â
  • Á¦Ç° ºÎ¹® ´ë½Ãº¸µå
  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø ¹× µ¿Ç⠺м®, Á¦Ç°º°, 2018-2030³â
  • dz¼± È®Àå °¡´É
  • ÀÚ°¡ È®Àå °¡´É
  • ±â°èÀûÀ¸·Î È®Àå °¡´É
  • ´ëµ¿¸ÆÆÇ ¿ª·ù

Á¦5Àå ´ëµ¿¸ÆÆÇ ġȯ ±â±â ½ÃÀå : º¯Ã·Àç·á ºñÁî´Ï½º ºÐ¼®

  • º¯Ã·Àç·á ½ÃÀå Á¡À¯À², 2024³â°ú 2030³â
  • º¯Ã·Àç·á ºÎ¹® ´ë½Ãº¸µå
  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø ¹× µ¿Ç⠺м®, º¯Ã·Àç·áº°, 2018-2030³â
  • ¼Ò ½É³¶
  • µÅÁö ½É³¶

Á¦6Àå ´ëµ¿¸ÆÆÇ ġȯ ±â±â ½ÃÀå : ÇÁ·¹ÀÓ Àç·á ºñÁî´Ï½º ºÐ¼®

  • ÇÁ·¹ÀÓ Àç·á ½ÃÀå Á¡À¯À², 2024³â ¹× 2030³â
  • ÇÁ·¹ÀÓ Àç·á ºÎ¹® ´ë½Ãº¸µå
  • ÇÁ·¹ÀÓ Àç·áº° ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø ¹× µ¿Ç⠺м®, 2018-2030³â
  • ÄÚ¹ßÆ® Å©·Ò
  • ´ÏƼ³î
  • ±âŸ

Á¦7Àå ´ëµ¿¸ÆÆÇ ġȯ ±â±â ½ÃÀå : ÃÖÁ¾ ¿ëµµ ºñÁî´Ï½º ºÐ¼®

  • ÃÖÁ¾ ¿ëµµ ½ÃÀå Á¡À¯À², 2024³â ¹× 2030³â
  • ÃÖÁ¾ ¿ëµµ ºÎ¹® ´ë½Ãº¸µå
  • ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø ¹× µ¿Ç⠺м®, ÃÖÁ¾ ¿ëµµº°, 2018-2030³â
  • ÀÔ¿ø ½Ã¼³
  • ¿Ü·¡ ½Ã¼³

Á¦8Àå ´ëµ¿¸ÆÆÇ ġȯ ±â±â ½ÃÀå : Á¦Ç°, ÆÇ¸· Àç·á, ÇÁ·¹ÀÓ Àç·á, ÃÖÁ¾ ¿ëµµº° Áö¿ªº° ÃßÁ¤¡¤µ¿Ç⠺м®

  • Áö¿ªº° ½ÃÀå Á¡À¯À² ºÐ¼®, 2024³â ¹× 2030³â
  • Áö¿ª ½ÃÀå ´ë½Ãº¸µå
  • ½ÃÀå ±Ô¸ð, ¿¹Ãø µ¿Ç⠺м®, 2018³â¿¡¼­ 2030³â :
  • ºÏ¹Ì
    • ±¹°¡º°, 2018-2030³â
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • ±¹°¡º°, 2018-2030³â
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ÀÌÅ»¸®¾Æ
    • ½ºÆäÀÎ
    • ³ë¸£¿þÀÌ
    • µ§¸¶Å©
    • ½º¿þµ§
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ±¹°¡º°, 2018-2030³â
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • Çѱ¹
    • È£ÁÖ
    • ű¹
  • ¶óƾ¾Æ¸Þ¸®Ä«
    • ±¹°¡º°, 2018-2030³â
    • ºê¶óÁú
    • ¾Æ¸£ÇîÆ¼³ª
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • ±¹°¡º°, 2018-2030³â
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • Äí¿þÀÌÆ®

Á¦9Àå °æÀï »óȲ

  • ÁøÃâ ±â¾÷ °³¿ä
  • ±â¾÷ÀÇ ½ÃÀå Æ÷Áö¼Ç ºÐ¼®
  • ±â¾÷ ºÐ·ù
  • Àü·« ¸ÅÇÎ
  • ±â¾÷ °³¿ä/»óÀå ±â¾÷
    • Boston Scientific Corporation
    • Artivion, Inc
    • Edwards Lifesciences Corporation
    • LivaNova PLC
    • Medtronic
    • Abbott
ksm 24.11.21

Aortic Valve Replacement Devices Market Growth & Trends:

The global aortic valve replacement devices market size is expected to reach USD 12.76 billion by 2030, registering a CAGR of 10.1% from 2025 to 2030, according to a new report by Grand View Research, Inc. Technological advancements in aortic valves and favorable reimbursement policies are boosting the growth of the market. Rising demand for minimally invasive surgeries is also triggering the growth of the market.

Widening base of geriatric population is one of the key growth stimulants. As per data published by Medicare and Medicaid services, the number of aortic stenosis patients over 65 years of age is constantly increasing in the U.S. Thus, rising incidence of aortic stenosis coupled with improving treatment rates is expected to bolster the growth of the market over the forecast period. In addition, growing preference for minimally invasive surgeries is escalating the growth of the market. These procedures cause lesser trauma to patient along with better outcomes and facilitate faster recovery than conventional open-heart surgeries. MIS requires relatively lesser number of hospital stays and is hence economically more viable than conventional invasive surgeries.

Favorable reimbursement policies are one of the crucial factors anticipated to drive the market in the near future. Centers for Medicare & Medicaid Services (CMS) announced that it would provide coverage for TAVR under the Medicare National Coverage Determination policy. Moreover, increasing number of clinical studies undertaken by key players for extending interventional scope, analyzing safety of devices, and assessing subsequent treatment alternatives is also working in favor of the market. However, product recalls due to safety concerns are projected to inhibit the growth of the market.

Aortic Valve Replacement Devices Market Report Highlights:

  • Balloon-expandable valves dominated the market with a revenue share of 68.7% in 2024. Balloon-expandable valves are increasingly preferred due to their lower risk of valve migration and reliable outcomes.
  • The bovine pericardium segment led the market with a revenue share of 72.5% in 2024, owing to its superior mechanical properties and biocompatibility.
  • Cobalt-chromium frames held the largest market share of 64.0% in 2024 and exhibit exceptional mechanical properties, including strength, durability, and corrosion resistance, making them ideal for TAVR device construction.
  • Inpatient facilities dominated the market and accounted for a share of 92.2% in 2024. Hospitals and clinics are equipped with advanced medical infrastructure, skilled personnel, and essential post-operative monitoring to manage potential complications from aortic valve surgeries.
  • North America aortic valve replacement devices market dominated the global market with a revenue share of 59.7% in 2024. North America boasts advanced healthcare infrastructure, a high prevalence of aortic stenosis, and substantial investments in medical technology.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Segment Definitions
    • 1.1.2. Product
    • 1.1.3. Leaflet Material
    • 1.1.4. Frame Material
    • 1.1.5. End Use
  • 1.2. Estimates and Forecast Timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
    • 1.4.3. Secondary Sources
    • 1.4.4. Primary Research
  • 1.5. Information Analysis
    • 1.5.1. Data Analysis Models
  • 1.6. Market Formulation & Data Visualization
  • 1.7. Model Details
    • 1.7.1. Commodity Flow Analysis
  • 1.8. List of Secondary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Aortic Valve Replacement Devices Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Aortic Valve Replacement Devices Market: Product Business Analysis

  • 4.1. Product Market Share, 2024 & 2030
  • 4.2. Product Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Balloon-expandable
    • 4.4.1. Balloon-expandable Market, 2018 - 2030 (USD Million)
  • 4.5. Self-expandable
    • 4.5.1. Self-expandable Market, 2018 - 2030 (USD Million)
  • 4.6. Mechanically Expandable
    • 4.6.1. Mechanically Expandable Market, 2018 - 2030 (USD Million)
  • 4.7. Aortic Regurgitation
    • 4.7.1. Aortic Regurgitation Market, 2018 - 2030 (USD Million)

Chapter 5. Aortic Valve Replacement Devices Market: Leaflet Material Business Analysis

  • 5.1. Leaflet Material Market Share, 2024 & 2030
  • 5.2. Leaflet Material Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Leaflet Material, 2018 to 2030 (USD Million)
  • 5.4. Bovine Pericardium
    • 5.4.1. Bovine Pericardium Market, 2018 - 2030 (USD Million)
  • 5.5. Porcine Pericardium
    • 5.5.1. Porcine Pericardium Market, 2018 - 2030 (USD Million)

Chapter 6. Aortic Valve Replacement Devices Market: Frame Material Business Analysis

  • 6.1. Frame Material Market Share, 2024 & 2030
  • 6.2. Frame Material Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Frame Material, 2018 to 2030 (USD Million)
  • 6.4. Cobalt-Chromium
    • 6.4.1. Cobalt-Chromium Market, 2018 - 2030 (USD Million)
  • 6.5. Nitinol
    • 6.5.1. Nitinol Market, 2018 - 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Aortic Valve Replacement Devices Market: End Use Business Analysis

  • 7.1. End Use Market Share, 2024 & 2030
  • 7.2. End Use Segment Dashboard
  • 7.3. Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 7.4. Inpatient Facilities
    • 7.4.1. Inpatient Facilities Market, 2018 - 2030 (USD Million)
  • 7.5. Outpatient Facilities
    • 7.5.1. Outpatient Facilities Market, 2018 - 2030 (USD Million)

Chapter 8. Aortic Valve Replacement Devices Market: Regional Estimates & Trend Analysis by Product, Leaflet Material, Frame Material, and End Use

  • 8.1. Regional Market Share Analysis, 2024 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 8.4. North America
    • 8.4.1. North America Aortic Valve Replacement Devices Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Regulatory Framework
      • 8.4.2.3. Competitive Insights
      • 8.4.2.4. U.S. Aortic Valve Replacement Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Regulatory Framework
      • 8.4.3.3. Competitive Insights
      • 8.4.3.4. Canada Aortic Valve Replacement Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. Mexico
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Regulatory Framework
      • 8.4.4.3. Competitive Insights
      • 8.4.4.4. Mexico Aortic Valve Replacement Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Europe
    • 8.5.1. Europe Aortic Valve Replacement Devices Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Regulatory Framework
      • 8.5.2.3. Competitive Insights
      • 8.5.2.4. UK Aortic Valve Replacement Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Regulatory Framework
      • 8.5.3.3. Competitive Insights
      • 8.5.3.4. Germany Aortic Valve Replacement Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Regulatory Framework
      • 8.5.4.3. Competitive Insights
      • 8.5.4.4. France Aortic Valve Replacement Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.5. Italy
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Regulatory Framework
      • 8.5.5.3. Competitive Insights
      • 8.5.5.4. Italy Aortic Valve Replacement Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.6. Spain
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Regulatory Framework
      • 8.5.6.3. Competitive Insights
      • 8.5.6.4. Spain Aortic Valve Replacement Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.7. Norway
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Regulatory Framework
      • 8.5.7.3. Competitive Insights
      • 8.5.7.4. Norway Aortic Valve Replacement Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.8. Denmark
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Regulatory Framework
      • 8.5.8.3. Competitive Insights
      • 8.5.8.4. Denmark Aortic Valve Replacement Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.9. Sweden
      • 8.5.9.1. Key Country Dynamics
      • 8.5.9.2. Regulatory Framework
      • 8.5.9.3. Competitive Insights
      • 8.5.9.4. Sweden Aortic Valve Replacement Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific Aortic Valve Replacement Devices Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Regulatory Framework
      • 8.6.2.3. Competitive Insights
      • 8.6.2.4. Japan Aortic Valve Replacement Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Regulatory Framework
      • 8.6.3.3. Competitive Insights
      • 8.6.3.4. China Aortic Valve Replacement Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Regulatory Framework
      • 8.6.4.3. Competitive Insights
      • 8.6.4.4. India Aortic Valve Replacement Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.5. South Korea
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Regulatory Framework
      • 8.6.5.3. Competitive Insights
      • 8.6.5.4. South Korea Aortic Valve Replacement Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.6. Australia
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Regulatory Framework
      • 8.6.6.3. Competitive Insights
      • 8.6.6.4. Australia Aortic Valve Replacement Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.7. Thailand
      • 8.6.7.1. Key Country Dynamics
      • 8.6.7.2. Regulatory Framework
      • 8.6.7.3. Competitive Insights
      • 8.6.7.4. Thailand Aortic Valve Replacement Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America Aortic Valve Replacement Devices Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Regulatory Framework
      • 8.7.2.3. Competitive Insights
      • 8.7.2.4. Brazil Aortic Valve Replacement Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Regulatory Framework
      • 8.7.3.3. Competitive Insights
      • 8.7.3.4. Argentina Aortic Valve Replacement Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.8. MEA
    • 8.8.1. MEA Aortic Valve Replacement Devices Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Regulatory Framework
      • 8.8.2.3. Competitive Insights
      • 8.8.2.4. South Africa Aortic Valve Replacement Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Regulatory Framework
      • 8.8.3.3. Competitive Insights
      • 8.8.3.4. Saudi Arabia Aortic Valve Replacement Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Regulatory Framework
      • 8.8.4.3. Competitive Insights
      • 8.8.4.4. UAE Aortic Valve Replacement Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Regulatory Framework
      • 8.8.5.3. Competitive Insights
      • 8.8.5.4. Kuwait Aortic Valve Replacement Devices Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Participant Overview
  • 9.2. Company Market Position Analysis
  • 9.3. Company Categorization
  • 9.4. Strategy Mapping
  • 9.5. Company Profiles/Listing
    • 9.5.1. Boston Scientific Corporation
      • 9.5.1.1. Overview
      • 9.5.1.2. Financial Performance
      • 9.5.1.3. Product Benchmarking
      • 9.5.1.4. Strategic Initiatives
    • 9.5.2. Artivion, Inc
      • 9.5.2.1. Overview
      • 9.5.2.2. Financial Performance
      • 9.5.2.3. Product Benchmarking
      • 9.5.2.4. Strategic Initiatives
    • 9.5.3. Edwards Lifesciences Corporation
      • 9.5.3.1. Overview
      • 9.5.3.2. Financial Performance
      • 9.5.3.3. Product Benchmarking
      • 9.5.3.4. Strategic Initiatives
    • 9.5.4. LivaNova PLC
      • 9.5.4.1. Overview
      • 9.5.4.2. Financial Performance
      • 9.5.4.3. Product Benchmarking
      • 9.5.4.4. Strategic Initiatives
    • 9.5.5. Medtronic
      • 9.5.5.1. Overview
      • 9.5.5.2. Financial Performance
      • 9.5.5.3. Product Benchmarking
      • 9.5.5.4. Strategic Initiatives
    • 9.5.6. Abbott
      • 9.5.6.1. Overview
      • 9.5.6.2. Financial Performance
      • 9.5.6.3. Product Benchmarking
      • 9.5.6.4. Strategic Initiatives
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦